ATR inhibitor AZD6738 (ceralasertib) exerts antitumor activity as a monotherapy and in combination with chemotherapy and the PARP inhibitor olaparib

出版年份 2022 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages canres.2997.2021

出版商

American Association for Cancer Research (AACR)

发表日期

2022-01-26

DOI

10.1158/0008-5472.can-21-2997

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now